FastCompany RSS

Topic: GlaxoSmithKline plc

  
   |  Comment

Tech Companies Still Top the Green Charts

Newsweek magazine may be in trouble, but its annual green rankings are one of the most comprehensive attempts to rank major companies based on sustainability. How does your company measure up?READ»

   |  Comment

Playing Kings: The CEO and President

In the third post of their 7-part series, John Elkington and Charmian Love look at how CEOs are coping with the new wild cards dealt by environmental, social and governance challenges.READ»

   |  Comment

Debbie Weil, Corporate Blogging Expert

Debbie Weil is known as the corporate blogging expert, and though she's no doubt earned the title -- she's worked for clients including GlaxoSmithKline and the American College of Radiology -- she can't help but find humor in the name.READ»

   |  Comment

Why You Should Start a Company in... Philadelphia

Fiesty as ever, Philly's famous Brotherly Love now extends to the innovating business community.READ»

   |  Comment

The 10 Most Addictive Sounds in the World

You're probably among the millions who have experienced it: driving in a car, listening to the radio, and suddenly this song comes on. It is not just any song--this was your favorite song when you were a teenager. As the first few ...READ»

   |  Comment

Outsourcing World Summit

Outsourcing means jobs go overseas, right? Not always. At this Orlando summit, Monty Hamilton, CEO of Atlanta-based Rural Sourcing, will explain how U.S. firms can save by moving work to the South. Rural Sourcing has centers in ...READ»

   |  Comment

Fast Company Recommended Events February 2010

February MON TUE WED THU FRI SAT SUN 01 02 03 04 05 06 07 08 09 10 11 12 13 ...READ»

   |  Comment

Paxil Once Again Stalks Potential Victims

The safety of drugs these days is a major issue not only with patients, but in the legal arena as med mal attorneys fight for justice for victims. READ»

   |  Comment

How to Work with More Meaning...and Get Paid

Why do you work?  As we emerge from the rubble of the Great Recession, more people from a variety of sectors and in different stages of life are searching for a more meaningful “why” behind the work they do. Paying the bills ...READ»

   |  Comment

The Gene Bubble: Why We Still Aren't Disease-Free

When the human genome was first sequenced nearly a decade ago, the world lit up with talk about how new gene-specific drugs would help us cheat death. Well, the verdict is in: Keep eating those greens.READ»

   |  Comment

Traditional Chasm Market Segmentation - Moving to the Max Segmentation Strategy

 Whole books have been written about market segmentation, so it is difficult to summarize it on a page. One of the leading segmentation methodologies, that became part of teaching at the Harvard Business School, is what we lived ...READ»

   |  Comment

GlaxoSmithKline Signs $540 Million Deal for Nicotine Vaccine

Four years ago, the startup Nabi Biopharmaceuticals began testing a promising nicotine vaccine called NicVax with the aid of $4.1 million in funding from the National Institutes of Health. Earlier today, the vaccine received a booster ...READ»

   |  Comment

Individual Health Insurance Reform Weekly : EasyToInsureME : July 23, 2009

Last week will go down as a truly significant week in health care reform. The House leadership unveiled its 1,000+ page bill and announced that the three committees of jurisdiction would immediately begin mark-up sessions designed to get a composite bill to the House floor by the end of July. Late last week the House Ways and Means Committee approved the House bill 23 to 18READ»

   |  Comment

GlaxoSmithKline Fights Malaria in Africa with Satellites

Malaria kills one million people a year, most of them children in Africa's so-called Malaria Belt (the sub-Saharan region). In partnership with the Gates Foundation, pharmaceuticals giant GlaxoSmithKline is preparing an ambitious ...READ»

   |  Comment

Rwanda Rising: A New Model of Economic Development

Fifteen years after the genocide, the small African country has embraced a new model of economic development. Its strategy: Build a global network of powerful friends to lure private investment -- and market the brand of Rwanda.READ»

   |  Comment

Wyeth's Multibillion-dollar Biotech Bet

Drugmaker Wyeth bet billions on biotech, transforming its culture and boosting profits.READ»

   |  Comment

Buy.ology: Why We Buy What We Do

It seems that I spend a great deal of time these days talking about the subconcious emotional drivers of designs. It turns out that there are very good reasons we all "buy" what we do. Reasons that are tied into our biology, ...READ»

   |  Comment

When The Thrill Is Gone, So Are They

Do you help your employees find the work they love to do? It may not always be easy, and you may even risk losing some of them. But if you don’t partner with your talented employees to find work they are passionate about, you will no doubt lose them anyway.READ»

   |  Comment

Openness, Generosity, and Accountability

Where do those attributes fit in today's bustling business world? Leaders at a recent conference learned firsthand.READ»

   |  Comment

Spare No Expense

Even the staunchest budget "hawk" understands that you can't cost-cut your way to growth.READ»

   |  Comment

Pharmaceutical blogs bring customers closer

In the super-regulated world of pharmaceuticals, some of the world’s largest corporations are using digital media to get closer to customers and advocates. GlaxoSmithKline and Johnson & Johnson are using blogs to engage in ...READ»

   |  Comment

Can CEOs Cure Cancer?

Big Pharma execs may not know more about the disease than the rest of us, but a group of them are using their power to fight it.READ»

   |  Comment

Medicine Man: Andrew Grant

What makes you feel good now looks even better.READ»

   |  Comment

Social Capitalists: Profiles

Path (Program for Appropriate Technology in Health) Founded: 1977 Seattle, Washington Christopher J. Elias, President www.path.org Entrepreneurship: A Innovation: A+ Social Impact: A+ Aspiration: A- Sustainability: A- ...READ»

   |  Comment

Fresh Start 2002: Roche's New Scientific Method

How does a giant pharmaceutical company reckon with genomics technology? By making a fresh start in how it recruits its scientists, manages projects, and uses computers. Here's how the Roche Group is reinventing how it invents.READ»